US Stocks
US Options
Emerging Asia
GBP Cash Savings
Charts & Tools
Paper Trading
Extended Hours
Overview
Desktop
Wall Street JournalA
APLS
Apellis Pharmace
41.05
1.76+4.48%After Hours: 41.05 0.00 0.00%18:59 09/06 EDT
OPEN/PREV CLOSE39.67/39.29
TODAY RANGE39.38-41.64
VOL1.85M
MARKET CAP5.00B
52 WEEK RANGE29.79-73.80
AVG VOL (3M)1.45M
% TURNOVER1.52%
TURNOVER--
P/E (TTM)-14.9790
% RANGE5.75%
EPS(TTM)-2.7405
P/E(FORWARD)-33.3848
P/B18.90
BVPS2.172
DIVIDEND--
P/S12.37
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP4.22B
SHARES OUTSTANDING121.77M
NEXT EARNINGS10/30-11/04
FREE FLOAT102.78M
LOT SIZE1
EX-DIV DATE--
News
Press Releases
Financial Reports
Profile
NASDAQ·1d ago
Notable Friday Option Activity: BRZE, DOCN, APLS
Seeking Alpha·08/27 15:45
PGIM Jennison Health Sciences Fund Q2 2024 Commentary
Simply Wall St·08/23 13:56
Possible Bearish Signals With Apellis Pharmaceuticals Insiders Disposing Stock
Dow Jones·08/13 12:41
Apellis Pharmaceuticals Price Target Cut to $64.00/Share From $72.00 by JP Morgan
Dow Jones·08/13 12:41
Apellis Pharmaceuticals Is Maintained at Overweight by JP Morgan
Reuters·08/13 07:22
U.S. RESEARCH ROUNDUP- Apollo, Blackstone, Hershey
Dow Jones·08/09 14:58
Apellis Pharmaceuticals Price Target Cut to $83.00/Share From $85.00 by UBS
Dow Jones·08/09 14:58
Apellis Pharmaceuticals Is Maintained at Buy by UBS
Benzinga·08/09 14:48
UBS Maintains Buy on Apellis Pharmaceuticals, Lowers Price Target to $83
Reuters·08/09 14:12
APELLIS PHARMACEUTICALS INC <APLS.O>: UBS CUTS TARGET PRICE TO $83 FROM $85
Dow Jones·08/09 14:08
Apellis Pharmaceuticals Is Maintained at Neutral by Wedbush
Same Industry
Name/Symbol
Change%
Price